Preliminary evaluation of safety and activity of recombinant human interleukin 11 in patients with active Crohn's disease (Q77921868)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10381910 AND SRC:MED&resulttype=core&format=json

9 December 2019

title

Preliminary evaluation of safety and activity of recombinant human interleukin 11 in patients with active Crohn's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10381910 AND SRC:MED&resulttype=core&format=json

9 December 2019

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10381910 AND SRC:MED&resulttype=core&format=json

9 December 2019

author name string

B E Sands

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10381910 AND SRC:MED&resulttype=core&format=json

9 December 2019

S Bank

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10381910 AND SRC:MED&resulttype=core&format=json

9 December 2019

C A Sninsky

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10381910 AND SRC:MED&resulttype=core&format=json

9 December 2019

M Robinson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10381910 AND SRC:MED&resulttype=core&format=json

9 December 2019

J W Singleton

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10381910 AND SRC:MED&resulttype=core&format=json

9 December 2019

P B Miner

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10381910 AND SRC:MED&resulttype=core&format=json

9 December 2019

M A Safdi

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10381910 AND SRC:MED&resulttype=core&format=json

9 December 2019

S Galandiuk

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10381910 AND SRC:MED&resulttype=core&format=json

9 December 2019

S B Hanauer

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10381910 AND SRC:MED&resulttype=core&format=json

9 December 2019

G W Varilek

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10381910 AND SRC:MED&resulttype=core&format=json

9 December 2019

A L Buchman

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10381910 AND SRC:MED&resulttype=core&format=json

9 December 2019

V D Rodgers

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10381910 AND SRC:MED&resulttype=core&format=json

9 December 2019

B Salzberg

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10381910 AND SRC:MED&resulttype=core&format=json

9 December 2019

B Cai

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10381910 AND SRC:MED&resulttype=core&format=json

9 December 2019

J Loewy

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10381910 AND SRC:MED&resulttype=core&format=json

9 December 2019

M F DeBruin

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10381910 AND SRC:MED&resulttype=core&format=json

9 December 2019

H Rogge

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10381910 AND SRC:MED&resulttype=core&format=json

9 December 2019

M Shapiro

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10381910 AND SRC:MED&resulttype=core&format=json

9 December 2019

U S Schwertschlag

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10381910 AND SRC:MED&resulttype=core&format=json

9 December 2019

language of work or name

English

0 references

publication date

1 July 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10381910 AND SRC:MED&resulttype=core&format=json

9 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10381910 AND SRC:MED&resulttype=core&format=json

9 December 2019

volume

117

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10381910 AND SRC:MED&resulttype=core&format=json

9 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10381910 AND SRC:MED&resulttype=core&format=json

9 December 2019

page(s)

58-64

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10381910 AND SRC:MED&resulttype=core&format=json

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

9 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(99)70550-0

Randomized placebo-controlled study of recombinant human interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with breast cancer receiving dose-intensive cyclophosphamide and doxorubicin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(99)70550-0

Effects of IL-11 on the growth of intestinal epithelial cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(99)70550-0

Protection of the small intestinal clonogenic stem cells from radiation-induced damage by pretreatment with interleukin 11 also increases murine survival time

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(99)70550-0

Protection by recombinant human interleukin-11 against experimental TNB-induced colitis in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(99)70550-0

Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(99)70550-0

Alteration in the frequency, severity and duration of chemotherapy-induced mucositis in hamsters by interleukin-11.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(99)70550-0

Mitigating effects of interleukin 11 on consecutive courses of 5-fluorouracil-induced ulcerative mucositis in hamsters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(99)70550-0

Immunosuppressive and anti-inflammatory properties of interleukin 10.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(99)70550-0

Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(99)70550-0

Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease. Crohn's Disease Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(99)70550-0

Administration of interleukin-10 abolishes innate resistance to Listeria monocytogenes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(99)70550-0

The biology of interleukin 11.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(99)70550-0

Advances in the assessment of disease activity in inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(99)70550-0

Vascular complications of inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(99)70550-0

Hemostatic tests in the prediction of atherothrombotic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(99)70550-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0016-5085(99)70550-0

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10381910 AND SRC:MED&resulttype=core&format=json

9 December 2019

1 reference